Why the study?
Does G-CSF enhance the migration of human mesenchymal stem cells towards SDF-1?
Does G-CSF enhance the migration of human mesenchymal stem cells towards SDF-1?
Answers are grounded in this paper and cite their sources.
G-CSF enhances the migration of human mesenchymal stem cells towards SDF-1 in a CXCR4-independent manner, suggesting a potential strategy for directing stem cells for cardiac repair.
Introduction: The mechanism by which bone marrow stem cells target an area of cardiac injury following myocardial infarction is unknown. Our hypotheses were: [1] granulocyte colony-stimulating factor (G-CSF) enhances the migration of human mesenchymal stem cells (hMSC) towards the chemokine, stromal-derived factor (SDF-1), and [2] CXCR4, the receptor for SDF-1, is required for the hMSC migration. SDF-1 and G-CSF are released during a myocardial infarction, and thus may play a role in stem cell mobilization and attraction. Methods: Migration assays were performed in dual-chamber culture wells containing 8-micron pore size matrigel inserts. SDF-1 was placed in the bottom chamber in all wells except for the control. Sternal bone marrow derived hMSCs were plated into upper chambers containing serum-free medium with and without G-CSF. After 24 hours, migrated cells were isolated and quantified using fluorescent staining. Membrane phenotyping was performed by immunofluorescence using a panel of monoclonal antibodies. Results: hMSC migration in response to SDF-1 was 11.4%(p<.02) greater than in control wells and 34%(p<.001)greater when hMSC were pre-exposed to G-CSF. The hMSCs expressed the membrane phenotype CD34(-), CD14(-), CXCR4(-), CD44(+), CD105(+), CD106(+). Conclusions: Exposing hMSCs to G-CSF can significantly enhance the homing capacity of these stem cells towards SDF-1. This chemoattraction did not require the SDF-1 receptor, CXCR4. Ongoing experiments suggest G-CSF may have enhanced stem cell migration through an interaction with the CD44(+) receptor, a homing cell adhesion molecule. Directing and amplifying the homing of endogenous stem cells, using pro-inflammatory chemokines, is a promising therapeutic strategy for reengineering the damaged myocardium.
No takes yet. Share an insight, caveat, or question.
Bolno et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: